Literature DB >> 25915146

Limitations of Current AHA Guidelines and Proposal of New Guidelines for the Preparticipation Examination of Athletes.

Tim P Dunn1, David Pickham, Sonya Aggarwal, Divya Saini, Nikhil Kumar, Matthew T Wheeler, Marco Perez, Euan Ashley, Victor F Froelicher.   

Abstract

OBJECTIVE: To examine the prevalence of athletes who screen positive with the preparticipation examination guidelines from the American Heart Association, the AHA 12-elements, in combination with 3 screening electrocardiogram (ECG) criteria.
DESIGN: Observational cross-sectional study.
SETTING: Stanford University Sports Medicine Clinic. PARTICIPANTS: Total of 1596 participants, including 297 (167 male; mean age, 16.2 years) high school athletes, 1016 (541 male; mean age, 18.8 years) collegiate athletes, and 283 (mean age, 26.3 years) male professional athletes. MAIN OUTCOME MEASURES: Athletes were screened using the 8 personal and family history questions from the AHA 12-elements. Electrocardiograms were obtained for all participants and interpreted using Seattle criteria, Stanford criteria, and European Society of Cardiology (ESC) recommendations.
RESULTS: Approximately one-quarter of all athletes (23.8%) had at least 1 positive response to the AHA personal and family history elements. High school and college athletes had similar rates of having at least 1 positive response (25.9% vs 27.4%), whereas professional athletes had a significantly lower rate of having at least 1 positive response (8.8%, P < 0.05). Females reported more episodes of unexplained syncope (11.4% vs 7.5%, P = 0.017) and excessive exertional dyspnea with exercise (11.1% vs 6.1%, P = 0.001) than males. High school athletes had more positive responses to the family history elements when compared with college athletes (P < 0.05). The percentage of athletes who had an abnormal ECG varied between Seattle criteria (6.0%), Stanford criteria (8.8%), and ESC recommendations (26.8%).
CONCLUSIONS: Many athletes screen positive under current screening recommendations, and ECG results vary widely by interpretation criteria. CLINICAL RELEVANCE: In a patient population without any adverse cardiovascular events, the currently recommended AHA 12-elements have an unacceptably high rate of false positives. Newer screening guidelines are needed, with fewer false positives and evidence-based updates.

Entities:  

Mesh:

Year:  2015        PMID: 25915146     DOI: 10.1097/JSM.0000000000000203

Source DB:  PubMed          Journal:  Clin J Sport Med        ISSN: 1050-642X            Impact factor:   3.638


  6 in total

1.  Interassociation Consensus Statement on Cardiovascular Care of College Student-Athletes.

Authors:  Brian Hainline; Jonathan Drezner; Aaron Baggish; Kimberly G Harmon; Michael S Emery; Robert J Myerburg; Eduardo Sanchez; Silvana Molossi; John T Parsons; Paul D Thompson
Journal:  J Athl Train       Date:  2016-04-25       Impact factor: 2.860

Review 2.  Cardiac screening to prevent sudden death in young athletes.

Authors:  Christopher Schmehil; Devika Malhotra; Dilip R Patel
Journal:  Transl Pediatr       Date:  2017-07

Review 3.  Current controversies in pre-participation cardiovascular screening for young competitive athletes.

Authors:  Bradley J Petek; Aaron L Baggish
Journal:  Expert Rev Cardiovasc Ther       Date:  2020-07-07

4.  Pre-participation Cardiovascular Screening in Young Competitive Athletes.

Authors:  Bradley J Petek; Aaron L Baggish
Journal:  Curr Emerg Hosp Med Rep       Date:  2020-05-21

5.  Performance of the American Heart Association ( AHA ) 14-Point Evaluation Versus Electrocardiography for the Cardiovascular Screening of High School Athletes: A Prospective Study.

Authors:  Elizabeth A Williams; Hank F Pelto; Brett G Toresdahl; Jordan M Prutkin; David S Owens; Jack C Salerno; Kimberly G Harmon; Jonathan A Drezner
Journal:  J Am Heart Assoc       Date:  2019-07-09       Impact factor: 5.501

6.  Incidence of sudden cardiac death in the young: a systematic review.

Authors:  Keith Couper; Oliver Putt; Richard Field; Kurtis Poole; William Bradlow; Aileen Clarke; Gavin D Perkins; Pamela Royle; Joyce Yeung; Sian Taylor-Phillips
Journal:  BMJ Open       Date:  2020-10-07       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.